Global ELISA Analyzers Market Size Study & Forecast, by Type (Optical Filter ELISA Analyzers, Optical Grating ELISA Analyzers), By Mode (Automated ELISA Analyzers, Semi-Automated ELISA Analyzers), By Application (Immunology, Vaccine development, Drug Moni

Global ELISA Analyzers Market Size Study & Forecast, by Type (Optical Filter ELISA Analyzers, Optical Grating ELISA Analyzers), By Mode (Automated ELISA Analyzers, Semi-Automated ELISA Analyzers), By Application (Immunology, Vaccine development, Drug Monitoring, Others), By End-user (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization, Diagnostic Laboratories), and Regional Analysis, 2023-2030

Global ELISA Analyzers Market is valued approximately at USD 567.88 million in 2022 and is anticipated to grow with a healthy growth rate of more than 3.7% over the forecast period 2023-2030. ELISA is a biological assay that uses antibodies and an enzyme-mediated color change to determine if an antigen (such as proteins, peptides, or hormones) or an antibody is present in a sample. Enzyme-linked immunosorbent assays are utilized as analytical and diagnostic tools in biological research. The presence and concentration of analytes in the test sample are determined by an ELISA analyzer. The rising inclination towards automated and portable ELISA systems, expansion of biopharmaceutical and biotechnology industries, spurring demand for personalized medicine, coupled with the surging number of drug discovery programs by pharmaceutical and biopharmaceutical companies are the most prominent factors that are propelling the market demand across the globe.

In addition, the increasing burden of chronic and infectious diseases is fueling the market expansion during the estimated period. The rising incidence of infectious diseases such as HIV/AIDS, hepatitis, and other viral infections have led to a growing demand for ELISA analyzers. According to HIV.gov, in 2021, it was estimated that nearly 38.4 million people globally are suffering from HIV, of which 1.7 million were children (<15 years old) and 36.7 million were adults. Also, in 2021, approximately 1.5 million individuals around the globe acquired HIV. Further, as per the World Health Organization report as of 2022, infections with the chronic hepatitis C virus affect an estimated 58 million individuals globally, and 1.5 million new cases are recorded each year. Infection with chronic hepatitis C affects an estimated 3.2 million children and adolescents. These analyzers are widely used for the detection and diagnosis of infectious agents, contributing to market growth. Moreover, the technological advancements in diagnostic testing, as well as the rising adoption of automation in the healthcare industry presents various lucrative opportunities over the forecasting years. However, the lack of skilled professionals and stringent regulatory policies for product approval are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global ELISA Analyzers Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the favorable reimbursement scenario, high adoption of technologically advanced ELISA products, and rising incidences of chronic & infectious diseases. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing investments in research and development, geographical expansion of key players in the region, increasing population, and high adoption of the automated and portable ELISA systems are significantly propelling the market demand across the region.

Major market players included in this report are:
Thermo Fisher Scientific
Abcam plc
Bio-Rad Laboratories
Merck KGaA
F. Hoffmann-La Roche Ltd.
Danaher Corporation
BioTech Corporation
Agilent Technologies
QIAGEN N.V.
PerkinElmer Inc.

Recent Developments in the Market:
In May 2022, Molecular Devices, LLC, a provider of life science solutions unveiled the introduction of the five pre-made work cells for automated enzyme-linked immunosorbent assay (ELISA) workflows. Additionally, the company aims on providing innovative automation for the time-consuming ELISA procedure through the launch.

In August 2021, Gold Standard Diagnostics Inc. merged with Virotech Diagnostics GmbH and Novatec Immundiagnostica GmbH. Additionally, through this partnership with Novatec Immundiagnostica GmbH, Gold Standard Diagnostics was able to add ELISA automated analyzers to its product line.

Global ELISA Analyzers Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Type, Mode, Application, End-user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
Optical Filter ELISA Analyzers
Optical Grating ELISA Analyzers

By Mode:
Automated ELISA Analyzers
Semi-Automated ELISA Analyzers

By Application:
Immunology
Vaccine development
Drug Monitoring
Others

By End-user:
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organization
Diagnostic Laboratories

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa


Companies
Thermo Fisher Scientific
Abcam plc
Bio-Rad Laboratories
Merck KGaA
F. Hoffmann-La Roche Ltd.
Danaher Corporation
BioTech Corporation
Agilent Technologies
QIAGEN N.V.
PerkinElmer Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.